Skip to main content
Clinical Trials/NCT05130944
NCT05130944
Completed
Not Applicable

Integrating Psychosocial Support Into Protection and Community Programs for Women in Ecuador and Panama

Columbia University1 site in 1 country275 target enrollmentSeptember 9, 2021

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Mental Health Wellness 1
Sponsor
Columbia University
Enrollment
275
Locations
1
Primary Endpoint
Attrition - proportion of enrolled individuals who drop out of the study
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

The purpose of the current protocol is to describe a cluster randomized feasibility trial examining the integration of a scalable stress management intervention into Entre Nosotras ('among/between us'), a community-based psychosocial intervention for migrant and host community women in Ecuador and Panamá.

Specifically the study aims to:

  1. Explore the relevance, acceptability, and feasibility of integrating a stress management intervention into community-based participatory women's group
  2. Examine the feasibility of conducting a fully-powered cluster randomized controlled trial evaluating the effectiveness and implementation of integrating a stress management intervention into a community-based participatory women's group as compared to community-based participatory women's groups alone.

Detailed Description

The proposed research directly targets two public health areas with major gaps in evidence in the field of humanitarian settings: (1) protection and safety, and (2) mental health and psychosocial wellbeing. This research will be conducted in three sites in Ecuador and Panama. Latin America has recently experienced increasing levels of forced migration due to political conflict, community violence, and other factors. Panamá and Ecuador host refugees, asylum seekers, and migrants from a range of Central and South American countries (e.g., Colombia, Nicaragua, Venezuela). Migrants in these contexts face mental health and psychosocial problems, threats to their safety, and disrupted social support systems. Gaps in psychosocial services to address these problems despite their high prevalence persist in both countries and have been exacerbated due to the COVID-19 pandemic.

Registry
clinicaltrials.gov
Start Date
September 9, 2021
End Date
March 8, 2022
Last Updated
2 years ago
Study Type
Interventional
Study Design
Parallel
Sex
Female

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Adult (18+ years) women residing in the study community who speak and understand Spanish
  • Displaced or host community members

Exclusion Criteria

  • Severe psychological distress (Kessler-6 \>=13)
  • Moderate or high risk of suicide
  • Cognitive impairment

Outcomes

Primary Outcomes

Attrition - proportion of enrolled individuals who drop out of the study

Time Frame: Up to 10 weeks

The proportion of enrolled individuals who drop out of the study will be used to indicate the feasibility of a fully-powered definitive trial.

Proportion of eligible and enrolled women who engage in sessions and/or complete all five group sessions.

Time Frame: Up to 5 weeks

This is to measure the acceptability of the intervention. Safety, an indicator of acceptability, will also be assessed by adverse events reported during study period. Qualitative interviews with participants and facilitators will inquire about acceptability and will be integrated with quantitative estimates of intervention engagement and completion.

Proportion of women screened who are eligible to participate

Time Frame: Baseline

This is to measure relevance of the intervention in the source population. Appropriateness of the intervention to population needs will be measured using quantitative indicators and qualitative reports from participants and facilitators during the process evaluation.

Intervention Usability Scale Score

Time Frame: 5 weeks

Usability will be measured using the 10-item Intervention Usability Scale, which will be completed by facilitators after the final session of the intervention. Scores are scaled to range from 0-100 with scores exceeding 68 considered to indicate usable interventions.

Number of baseline imbalances between study conditions

Time Frame: Baseline

The number of socio-demographic or study outcome imbalances between the intervention and comparison condition will be used to determine the feasibility of a fully-powered definitive trial and the success of the randomization process.

Recruitment rate

Time Frame: Study period

The number of individuals enrolled per month will be used to determine the feasibility of a fully-powered definitive trial.

Contamination - proportion of sessions that did not include coping skills intervention components

Time Frame: Up to 5 weeks

The proportion of experimental sessions that did not include coping skills intervention components and the proportion of control sessions that did include coping skills intervention components from the Doing What Matters in Times of Stress intervention.

Fidelity checklist score

Time Frame: Up to 5 weeks

Average level of compliance with the intervention activities as intended within the manual. Assessed using a fidelity checklist with average item scores ranging from 0 = not implemented to 2 = implemented well. Scores between 0 and 2 indicate that the activities were partially implemented and/or could be improved.

Facilitator competence score

Time Frame: Up to 5 weeks

This is to measure the feasibility of the intervention. Facilitator competencies assessed using items from ENACT along qualitative interviews with facilitators will be assessed together. For the quantitative items, we selected six domains that are each scored on a scale from 1=needs improvement to 3=done well.

Secondary Outcomes

  • Kessler 6 scale score(Baseline, Post-Intervention (approximately 5 Weeks), 5 Weeks Post-Intervention (approximately 10 Weeks))
  • Oslo Social Support Scale Score(Baseline, Post-Intervention (approximately 5 Weeks), 5 Weeks Post-Intervention (approximately 10 Weeks))
  • Brief COPE scale score(Baseline, Post-Intervention (approximately 5 Weeks), 5 Weeks Post-Intervention (approximately 10 Weeks))
  • Personal Wellbeing Index(Baseline, Post-Intervention (approximately 5 Weeks), 5 Weeks Post-Intervention (approximately 10 Weeks))
  • WHODAS Score(Baseline, Post-Intervention (approximately 5 Weeks), 5 Weeks Post-Intervention (approximately 10 Weeks))

Study Sites (1)

Loading locations...

Similar Trials